List of bibliographic references
Number of relevant bibliographic references: 4.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Aged |
| 4 | Female |
| 4 | Humans |
| 4 | Middle Aged |
| 3 | Adult |
| 3 | Breast Neoplasms (pathology) |
| 2 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 2 | Breast Neoplasms (drug therapy) |
| 2 | Breast Neoplasms (radiotherapy) |
| 2 | Breast Neoplasms (surgery) |
| 2 | Breast Neoplasms (therapy) |
| 2 | Cyclophosphamide (administration & dosage) |
| 2 | Fluorouracil (administration & dosage) |
| 2 | Prospective Studies |
| 2 | Radiotherapy Dosage |
| 2 | Retrospective Studies |
| 1 | Aged, 80 and over |
| 1 | Analysis of Variance |
| 1 | Angiogenesis Inhibitors (adverse effects) |
| 1 | Antibodies, Monoclonal, Humanized (adverse effects) |
| 1 | Antineoplastic Agents, Hormonal (administration & dosage) |
| 1 | Bevacizumab |
| 1 | Carcinoma, Ductal, Breast (pathology) |
| 1 | Carcinoma, Ductal, Breast (therapy) |
| 1 | Carcinoma, Lobular (pathology) |
| 1 | Carcinoma, Lobular (therapy) |
| 1 | Chemoradiotherapy, Adjuvant (adverse effects) |
| 1 | Chemotherapy, Adjuvant |
| 1 | Combined Modality Therapy |
| 1 | Combined Modality Therapy (methods) |
| 1 | Dermatitis (etiology) |
| 1 | Disease-Free Survival |
| 1 | Drug Administration Schedule |
| 1 | Dyspnea (etiology) |
| 1 | Esophagitis (etiology) |
| 1 | Estrogen Antagonists (administration & dosage) |
| 1 | Fibrosis |
| 1 | Follow-Up Studies |
| 1 | Inflammatory Breast Neoplasms (drug therapy) |
| 1 | Inflammatory Breast Neoplasms (pathology) |
| 1 | Inflammatory Breast Neoplasms (radiotherapy) |
| 1 | Inflammatory Breast Neoplasms (surgery) |
| 1 | Lymphedema (etiology) |
| 1 | Mastectomy, Segmental |
| 1 | Mitoxantrone (administration & dosage) |
| 1 | Neoadjuvant Therapy |
| 1 | Neoadjuvant Therapy (methods) |
| 1 | Neoplasm Recurrence, Local |
| 1 | Neoplasm Recurrence, Local (pathology) |
| 1 | Neoplasm Recurrence, Local (surgery) |
| 1 | Neoplasm Staging |
| 1 | Nitriles (administration & dosage) |
| 1 | Postmenopause |
| 1 | Radiation Injuries (etiology) |
| 1 | Radiation-Sensitizing Agents (adverse effects) |
| 1 | Skin (pathology) |
| 1 | Skin Pigmentation |
| 1 | Survival Rate |
| 1 | Tamoxifen (administration & dosage) |
| 1 | Telangiectasis (etiology) |
| 1 | Treatment Outcome |
| 1 | Triazoles (administration & dosage) |
| 1 | Vinblastine (administration & dosage) |
| 1 | Vinblastine (analogs & derivatives) |
| 1 | Vindesine (administration & dosage) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Alain Fourquet"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Alain Fourquet" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Alain Fourquet
}}
| This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024 |  |
